Page last updated: 2024-11-04

sotalol and Myotonic Dystrophy

sotalol has been researched along with Myotonic Dystrophy in 1 studies

Sotalol: An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.
sotalol : A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is substituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias.

Myotonic Dystrophy: Neuromuscular disorder characterized by PROGRESSIVE MUSCULAR ATROPHY; MYOTONIA, and various multisystem atrophies. Mild INTELLECTUAL DISABILITY may also occur. Abnormal TRINUCLEOTIDE REPEAT EXPANSION in the 3' UNTRANSLATED REGIONS of DMPK PROTEIN gene is associated with Myotonic Dystrophy 1. DNA REPEAT EXPANSION of zinc finger protein-9 gene intron is associated with Myotonic Dystrophy 2.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cohen, MB1
Snow, JS1
Merkatz, KA1
Kholwadwala, D1
Jadonath, RL1
Goldner, BG1
Cohen, TJ1

Other Studies

1 other study available for sotalol and Myotonic Dystrophy

ArticleYear
Suppression of ventricular tachycardia by sotalol in myotonic dystrophy.
    American heart journal, 1996, Volume: 132, Issue:2 Pt 1

    Topics: Adrenergic beta-Antagonists; Adult; Anti-Arrhythmia Agents; Electrocardiography; Humans; Male; Myoto

1996